Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: medium chain triglycerides; sodium oleate; glycerol; sodium hydroxide; water for injections; egg lecithin; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

USA - engelska - NLM (National Library of Medicine)

zoetis inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol 10 mg in 1 ml - propofol is an intravenous anesthetic injection for use in dogs as follows: 1. for induction of anesthesia. 2. for maintenance of general anesthesia for up to 20 minutes. 3. for induction of general anesthesia where maintenance is provided by inhalant anesthetics. propofol injection is contraindicated in dogs with a known hypersensitivity to propofol or its components, or when general anesthesia or sedation are contraindicated. not for human use. keep out of the reach of children. rare cases of self-administration have been reported, including fatalities. propofol should be managed to prevent the risk of diversion, through such measures as restriction of access and the use of drug accountability procedures appropriate to the clinical setting. exercise caution to avoid accidental self-injection. overdose is likely to cause cardiorespiratory depression (such as hypotension, bradycardia and/ or apnea). remove the individual from the source of exposure and seek medical attention. respiratory depression shou

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: soya oil; glycerol; egg lecithin; sodium oleate; sodium hydroxide; water for injections - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: soya oil; glycerol; egg lecithin; sodium oleate; sodium hydroxide; water for injections - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: sodium oleate; glycerol; egg lecithin; sodium hydroxide; water for injections; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. anesia 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. anesia 1% may also be used in adults for sedation of ventilated patients receiving intensive care. anesia 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: egg lecithin; soya oil; sodium oleate; water for injections; sodium hydroxide; glycerol - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium oleate; glycerol; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: sodium oleate; egg lecithin; glycerol; water for injections; soya oil; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.

Kanada - engelska - Health Canada

marcan pharmaceuticals inc - propofol - emulsion - 10mg - propofol 10mg

Irland - engelska - HPRA (Health Products Regulatory Authority)

uab norameda - propofol - emulsion for inj/inf - 10 mg/ml - other general anesthetics